« Back
Home /
GLP-1 receptor agonist 4

GLP-1 receptor agonist 4

Item no.	HY-129657-1ea
Manufacturer	MedChem Express
CASRN	1187061-62-6
Amount	1 ea
Quantity options	100 mg 1 ea
Category	Inhibitors & Compound Libraries Small Molecules
Type	Small Molecules
Specific against	other
Formula	C51H44Cl2N4O6
Citations	[1]Adnan M.M. Mjalli,et al. Oxadiazoanthracene compounds for the treatment of diabetes. WO2009111700A2.
Smiles	O=C(O)[C@@H](NC([C@@H]1CC2=C(CN1[C@H](C3=CC=CC=C3)CC)C=C(O[C@H](C4=CC=C(OCC5=CC=C(Cl)C(Cl)=C5)C=C4)C(N6C)=O)C6=C2)=O)CC7=CC=C(C8=CC=C(C#N)C=C8)C=C7
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Product Description	GLP-1 receptor agonist 4 is a glucagon-like peptide-1 receptor (GLP-1R) agonist extracted from patent WO2009111700A2, compound 87, has an EC50 of 64.5 nM. GLP-1 receptor agonist 4 can be used in the research for treatment of diabetes[1].
Shipping	Room temperature
Manufacturers Applications	Metabolism-sugar/lipid metabolism
MolecularWeight	879.82
Clinical Information	No Development Reported
Manufacturers Research Area	Metabolic Disease
Solubility	10 mM in DMSO
Target	GCGR
Manufacturers Target	GCGR
Manufacturers Pathway	GPCR/G Protein
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 ea

available

Request delivery time